HealthKey

HealthKey, based in London, United Kingdom, operates an API-integrated platform connecting insurers, employers, gyms, and benefit platforms with over 75 health and wellbeing providers. The company has successfully raised $1.62 million in total funding from notable investors including Plug and Play Insurtech Europe, Cur8 Capital, Oxford Capital Partners, Ascension, and Aviva Ventures. HealthKey simplifies access to personalized, preventative healthcare services, including instant medical care and wellness offerings, particularly for remote or high-risk workforces, removing barriers to proactive health solutions. Founded in 2022 by Co-Founder and CEO David Joerring, the platform employs 5 individuals. Recent partnerships include Veriforce for custom health benefits in the oil & gas sector and Endurance Zone, offering members free or discounted access to over 200 health services.

High-Level Overview

HealthKey is an AI-powered platform designed to identify and qualify patients for clinical trials by integrating directly with doctors’ electronic health records (EHR). It automates the traditionally manual and time-consuming process of matching patients to trial eligibility criteria, enabling clinics to boost enrollment rates, reduce screen failures, and maximize revenue from clinical trials. The platform serves clinical trial coordinators, research teams, and healthcare organizations by providing a prescreened, ranked list of eligible patients, thus accelerating patient recruitment and improving trial efficiency[1][2][5].

For an investment firm, HealthKey represents a cutting-edge solution in the intersection of AI, healthcare, and clinical research, addressing a critical bottleneck in clinical trial operations. Its mission centers on leveraging AI to transform patient identification, with a focus on healthcare and life sciences sectors. The company’s impact on the startup ecosystem lies in pioneering AI applications that streamline clinical research workflows, potentially reducing trial costs and speeding up drug development timelines[1][4].

Origin Story

HealthKey was founded by Josh Sabol, who recognized the inefficiencies in the manual patient identification process for clinical trials. The idea emerged from the challenge that doctors and research sites face in sifting through dense medical records to find patients who meet complex inclusion and exclusion criteria. Early traction included processing thousands of patient records monthly and helping a customer who had previously missed $1.4 million in revenue due to enrollment shortfalls to identify hundreds of eligible patients, thus improving trial enrollment outcomes[1][3].

Core Differentiators

• AI-Driven Prescreening: HealthKey uses advanced AI to analyze both structured and unstructured data from EHRs, including scanned documents like faxed PDFs, to match patients against detailed trial criteria with high accuracy[1][5].
• Integration with EHR Systems: Direct connection to clinics’ EHRs enables seamless data access and rapid patient identification without disrupting clinical workflows[2][4].
• Doctor-in-the-Loop Review: Provides a dashboard where doctors can review AI-identified candidates with highlighted evidence from medical records, ensuring clinical validation and continuous system improvement[1][5].
• HIPAA Compliance: Ensures patient data privacy and security, meeting regulatory standards critical in healthcare[2][4].
• Efficiency and Revenue Impact: Automates a labor-intensive process, freeing up staff time and enabling sites to meet enrollment targets and capture full revenue potential from clinical trials[1][5].

Role in the Broader Tech Landscape

HealthKey rides the growing trend of applying AI and real-world data (RWD) analytics to clinical research, a sector under pressure to accelerate trial timelines and reduce costs. The timing is favorable due to increasing digitization of health records and the pharmaceutical industry's demand for faster patient recruitment. Market forces such as the high cost of clinical trials and the complexity of eligibility criteria create strong demand for AI-driven solutions that improve trial efficiency and patient matching accuracy. HealthKey contributes to the broader ecosystem by enabling more effective use of EHR data, potentially influencing future trial designs and external control arm development[6].

Quick Take & Future Outlook

Looking ahead, HealthKey is poised to expand its impact by scaling integration with more healthcare providers and clinical trial sites, refining its AI models with ongoing user feedback, and potentially broadening its platform to support more complex trial designs and diverse therapeutic areas. Trends such as increased adoption of AI in healthcare, regulatory encouragement for real-world evidence, and the push for decentralized trials will shape its growth trajectory. HealthKey’s influence may evolve from a patient identification tool to a comprehensive clinical trial acceleration platform, further transforming how trials are conducted and how patients access cutting-edge treatments[6][7].

This positions HealthKey as a critical enabler in the future of clinical research, helping to unlock the full potential of AI to improve patient outcomes and streamline drug development.